EDESA BIOTECH, INC.

EDSA
Delayed Quote. Delayed  - 11/27 01:00:00 pm
5.27USD -0.57%
Prev.5.3000
Open5.3100
High5.4756
Low5.2100
Volume49 473
Latest news
11/03
10/19
08/12
07/30
Chart EDESA BIOTECH, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBullish
Resistance6,039,459,00
Spread/Res.-13%-44%-41%
Spread/Supp.5,8%84%46%
Support4,982,873,60
Financials
Sales 2020 0,31 M - -
Net income 2020 -6,10 M - -
Net Debt 2020 - - -
P/E ratio 2020 -7,57x
Yield 2020 -
Capitalization 50,9 M 50,9 M -
Capi. / Sales 2020 164x
Capi. / Sales 2021 255x
Nbr of Employees 10
Free-Float 52,9%
Company
Edesa Biotech Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic allergic...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
No events available

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 2
Average target price 13,00 $
Last Close Price 5,30 $
Spread / Highest target 202%
Spread / Average Target 145%
Spread / Lowest Target 88,7%